These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease. Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049 [TBL] [Abstract][Full Text] [Related]
12. AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models. Ivachtchenko AV; Ivanenkov YA; Veselov MS; Okun IM Curr Alzheimer Res; 2017; 14(3):268-294. PubMed ID: 27829340 [TBL] [Abstract][Full Text] [Related]
13. AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease. Ivachtchenko AV; Lavrovsky Y; Ivanenkov YA Mol Pharm; 2016 Mar; 13(3):945-63. PubMed ID: 26886442 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and computer-aided analysis of the role of linker for novel ligands of the 5-HT Łażewska D; Kurczab R; Więcek M; Satała G; Kieć-Kononowicz K; Handzlik J Bioorg Chem; 2019 Mar; 84():319-325. PubMed ID: 30530073 [TBL] [Abstract][Full Text] [Related]